世界の多形性膠芽腫(GBM)治療市場インサイト及び予測(~2026年)

【英語タイトル】Global Glioblastoma Multiforme Treatment (GBM) Market Size, Status and Forecast 2020-2026

QYResearchが出版した調査資料(QYR20NV12056)・商品コード:QYR20NV12056
・発行会社(調査会社):QYResearch
・発行日:2020年11月(※2024年版があります。お問い合わせください)
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは多形性膠芽腫(GBM)治療の世界市場について調査・分析した資料です。種類別(化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー)の市場規模、用途別(ベバコズマブ、カルムスチン、テモゾロミド)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別多形性膠芽腫(GBM)治療の競争状況、市場シェア
・世界の多形性膠芽腫(GBM)治療市場:種類別市場規模 2015年-2020年(化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー)
・世界の多形性膠芽腫(GBM)治療市場:種類別市場規模予測 2021年-2026年(化学療法、放射線療法、遺伝子治療、分子バイオテクノロジー)
・世界の多形性膠芽腫(GBM)治療市場:用途別市場規模 2015年-2020年(ベバコズマブ、カルムスチン、テモゾロミド)
・世界の多形性膠芽腫(GBM)治療市場:用途別市場規模予測 2021年-2026年(ベバコズマブ、カルムスチン、テモゾロミド)
・北米の多形性膠芽腫(GBM)治療市場分析:米国、カナダ
・ヨーロッパの多形性膠芽腫(GBM)治療市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの多形性膠芽腫(GBM)治療市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の多形性膠芽腫(GBM)治療市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの多形性膠芽腫(GBM)治療市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Merck、Teva Pharmaceutical、Arbor Pharmaceuticals、Sun Pharmaceutical、Roche
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論
【レポートの概要】

Glioblastoma is a fast-growing, aggressive type of central nervous system tumor that forms on the supportive tissue of the brain.
Global glioblastoma multiforme treatment market is expected to witness significant growth over the forecast period owing to the rising incidence of oncology diseases and rising geriatric population base.

Market Analysis and Insights: Global Glioblastoma Multiforme Treatment (GBM) Market
The global Glioblastoma Multiforme Treatment (GBM) market size is projected to reach US$ 654.6 million by 2026, from US$ 625.8 million in 2020, at a CAGR of 4.3%% during 2021-2026.

Global Glioblastoma Multiforme Treatment (GBM) Scope and Market Size
Glioblastoma Multiforme Treatment (GBM) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glioblastoma Multiforme Treatment (GBM) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Teva Pharmaceutical
Arbor Pharmaceuticals
Sun Pharmaceutical
Roche

Market segment by Type, the product can be split into
Chemotherapy
Radiotherapy
Gene therapy
Molecular biotechnology
Market segment by Application, split into
Bevacozumab
Carmustine
Temozolomide

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Glioblastoma Multiforme Treatment (GBM) Revenue
1.4 Market by Type
1.4.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiotherapy
1.4.4 Gene therapy
1.4.5 Molecular biotechnology
1.5 Market by Application
1.5.1 Global Glioblastoma Multiforme Treatment (GBM) Market Share by Application: 2020 VS 2026
1.5.2 Bevacozumab
1.5.3 Carmustine
1.5.4 Temozolomide
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Perspective (2015-2026)
2.2 Global Glioblastoma Multiforme Treatment (GBM) Growth Trends by Regions
2.2.1 Glioblastoma Multiforme Treatment (GBM) Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Glioblastoma Multiforme Treatment (GBM) Historic Market Share by Regions (2015-2020)
2.2.3 Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Glioblastoma Multiforme Treatment (GBM) Market Growth Strategy
2.3.6 Primary Interviews with Key Glioblastoma Multiforme Treatment (GBM) Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Glioblastoma Multiforme Treatment (GBM) Players by Market Size
3.1.1 Global Top Glioblastoma Multiforme Treatment (GBM) Players by Revenue (2015-2020)
3.1.2 Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Players (2015-2020)
3.1.3 Global Glioblastoma Multiforme Treatment (GBM) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Glioblastoma Multiforme Treatment (GBM) Market Concentration Ratio
3.2.1 Global Glioblastoma Multiforme Treatment (GBM) Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Glioblastoma Multiforme Treatment (GBM) Revenue in 2019
3.3 Glioblastoma Multiforme Treatment (GBM) Key Players Head office and Area Served
3.4 Key Players Glioblastoma Multiforme Treatment (GBM) Product Solution and Service
3.5 Date of Enter into Glioblastoma Multiforme Treatment (GBM) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Glioblastoma Multiforme Treatment (GBM) Historic Market Size by Type (2015-2020)
4.2 Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)
5.2 Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
6.2 Glioblastoma Multiforme Treatment (GBM) Key Players in North America (2019-2020)
6.3 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
6.4 North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

7 Europe
7.1 Europe Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
7.2 Glioblastoma Multiforme Treatment (GBM) Key Players in Europe (2019-2020)
7.3 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
7.4 Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

8 China
8.1 China Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
8.2 Glioblastoma Multiforme Treatment (GBM) Key Players in China (2019-2020)
8.3 China Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
8.4 China Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

9 Japan
9.1 Japan Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
9.2 Glioblastoma Multiforme Treatment (GBM) Key Players in Japan (2019-2020)
9.3 Japan Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
9.4 Japan Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
10.2 Glioblastoma Multiforme Treatment (GBM) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
10.4 Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

11 India
11.1 India Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
11.2 Glioblastoma Multiforme Treatment (GBM) Key Players in India (2019-2020)
11.3 India Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
11.4 India Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Glioblastoma Multiforme Treatment (GBM) Market Size (2015-2020)
12.2 Glioblastoma Multiforme Treatment (GBM) Key Players in Central & South America (2019-2020)
12.3 Central & South America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020)
12.4 Central & South America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Glioblastoma Multiforme Treatment (GBM) Introduction
13.1.4 Merck Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Teva Pharmaceutical
13.2.1 Teva Pharmaceutical Company Details
13.2.2 Teva Pharmaceutical Business Overview
13.2.3 Teva Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Introduction
13.2.4 Teva Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020)
13.2.5 Teva Pharmaceutical Recent Development
13.3 Arbor Pharmaceuticals
13.3.1 Arbor Pharmaceuticals Company Details
13.3.2 Arbor Pharmaceuticals Business Overview
13.3.3 Arbor Pharmaceuticals Glioblastoma Multiforme Treatment (GBM) Introduction
13.3.4 Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020)
13.3.5 Arbor Pharmaceuticals Recent Development
13.4 Sun Pharmaceutical
13.4.1 Sun Pharmaceutical Company Details
13.4.2 Sun Pharmaceutical Business Overview
13.4.3 Sun Pharmaceutical Glioblastoma Multiforme Treatment (GBM) Introduction
13.4.4 Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020)
13.4.5 Sun Pharmaceutical Recent Development
13.5 Roche
13.5.1 Roche Company Details
13.5.2 Roche Business Overview
13.5.3 Roche Glioblastoma Multiforme Treatment (GBM) Introduction
13.5.4 Roche Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020)
13.5.5 Roche Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Glioblastoma Multiforme Treatment (GBM) Key Market Segments
Table 2. Key Players Covered: Ranking by Glioblastoma Multiforme Treatment (GBM) Revenue
Table 3. Ranking of Global Top Glioblastoma Multiforme Treatment (GBM) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Gene therapy
Table 8. Key Players of Molecular biotechnology
Table 9. Global Glioblastoma Multiforme Treatment (GBM) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions (2015-2020)
Table 13. Global Glioblastoma Multiforme Treatment (GBM) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Glioblastoma Multiforme Treatment (GBM) Market Growth Strategy
Table 19. Main Points Interviewed from Key Glioblastoma Multiforme Treatment (GBM) Players
Table 20. Global Glioblastoma Multiforme Treatment (GBM) Revenue by Players (2015-2020) (Million US$)
Table 21. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Players (2015-2020)
Table 22. Global Top Glioblastoma Multiforme Treatment (GBM) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme Treatment (GBM) as of 2019)
Table 23. Global Glioblastoma Multiforme Treatment (GBM) by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Glioblastoma Multiforme Treatment (GBM) Product Solution and Service
Table 26. Date of Enter into Glioblastoma Multiforme Treatment (GBM) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 29. Global Glioblastoma Multiforme Treatment (GBM) Market Size Share by Type (2015-2020)
Table 30. Global Glioblastoma Multiforme Treatment (GBM) Revenue Market Share by Type (2021-2026)
Table 31. Global Glioblastoma Multiforme Treatment (GBM) Market Size Share by Application (2015-2020)
Table 32. Global Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 33. Global Glioblastoma Multiforme Treatment (GBM) Market Size Share by Application (2021-2026)
Table 34. North America Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 36. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 37. North America Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 38. North America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 39. North America Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 40. Europe Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 42. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 44. Europe Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 46. China Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 47. China Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 48. China Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 49. China Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 50. China Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 51. China Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 52. Japan Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 54. Japan Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 56. Japan Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 60. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 62. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 64. India Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 65. India Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 66. India Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 67. India Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 68. India Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 69. India Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Glioblastoma Multiforme Treatment (GBM) Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Glioblastoma Multiforme Treatment (GBM) Market Share (2019-2020)
Table 72. Central & South America Glioblastoma Multiforme Treatment (GBM) Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Glioblastoma Multiforme Treatment (GBM) Market Share by Type (2015-2020)
Table 74. Central & South America Glioblastoma Multiforme Treatment (GBM) Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Glioblastoma Multiforme Treatment (GBM) Market Share by Application (2015-2020)
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Product
Table 79. Merck Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020) (Million US$)
Table 80. Merck Recent Development
Table 81. Teva Pharmaceutical Company Details
Table 82. Teva Pharmaceutical Business Overview
Table 83. Teva Pharmaceutical Product
Table 84. Teva Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020) (Million US$)
Table 85. Teva Pharmaceutical Recent Development
Table 86. Arbor Pharmaceuticals Company Details
Table 87. Arbor Pharmaceuticals Business Overview
Table 88. Arbor Pharmaceuticals Product
Table 89. Arbor Pharmaceuticals Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020) (Million US$)
Table 90. Arbor Pharmaceuticals Recent Development
Table 91. Sun Pharmaceutical Company Details
Table 92. Sun Pharmaceutical Business Overview
Table 93. Sun Pharmaceutical Product
Table 94. Sun Pharmaceutical Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020) (Million US$)
Table 95. Sun Pharmaceutical Recent Development
Table 96. Roche Company Details
Table 97. Roche Business Overview
Table 98. Roche Product
Table 99. Roche Revenue in Glioblastoma Multiforme Treatment (GBM) Business (2015-2020) (Million US$)
Table 100. Roche Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Gene therapy Features
Figure 5. Molecular biotechnology Features
Figure 6. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Application: 2020 VS 2026
Figure 7. Bevacozumab Case Studies
Figure 8. Carmustine Case Studies
Figure 9. Temozolomide Case Studies
Figure 10. Glioblastoma Multiforme Treatment (GBM) Report Years Considered
Figure 11. Global Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions: 2020 VS 2026
Figure 13. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Glioblastoma Multiforme Treatment (GBM) Market Share by Players in 2019
Figure 16. Global Top Glioblastoma Multiforme Treatment (GBM) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glioblastoma Multiforme Treatment (GBM) as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Glioblastoma Multiforme Treatment (GBM) Revenue in 2019
Figure 18. North America Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Glioblastoma Multiforme Treatment (GBM) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed


【掲載企業】

Merck、Teva Pharmaceutical、Arbor Pharmaceuticals、Sun Pharmaceutical、Roche

★調査レポート[世界の多形性膠芽腫(GBM)治療市場インサイト及び予測(~2026年)] (コード:QYR20NV12056)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の多形性膠芽腫(GBM)治療市場インサイト及び予測(~2026年)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆